Glutamate antagonists: deadly liaisons with cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment.Molecular cancer · 2025
   Review
2. Sugar substitutes and taste enhancers need more science, sensitivity- and allergy-guided labeling.NPJ science of food · 2023
   Article
3. The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies.Medical oncology (Northwood, London, England) · 2022
   Review
4. Acetylation-dependent glutamate receptor GluR signalosome formation for STAT3 activation in both transcriptional and metabolism regulation.Cell death discovery · 2021
   Article
5. Accelerated cancer aggressiveness by viral oncomodulation: New targets and newer natural treatments for cancer control and treatment.Surgical neurology international · 2019
   Review
6. Dipeptide Prodrugs of the Glutamate Modulator Riluzole.ACS medicinal chemistry letters · 2018
   Article
7. Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas.Oncotarget · 2017
   Review
8. A Genome Wide Study of Copy Number Variation Associated with Nasopharyngeal Carcinoma in Malaysian Chinese Identifies CNVs at 11q14.3 and 6p21.3 as Candidate Loci.PloS one · 2016
   Article
9. Landscape of gene fusions in epithelial cancers: seq and ye shall find.Genome medicine · 2015
   Review
10. AMPA/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis.Annals of the rheumatic diseases · 2015
    Article
11. Targeting putative mu opioid/metabotropic glutamate receptor-5 heteromers produces potent antinociception in a chronic murine bone cancer model.European journal of pharmacology · 2014
    Article
12. Glutamate secretion and metabotropic glutamate receptor 1 expression during Kaposi's sarcoma-associated herpesvirus infection promotes cell proliferation.PLoS pathogens · 2014
    Article
13. Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.International journal of biological sciences · 2013
    Review
14. The association between cancer and amyotrophic lateral sclerosis.Cancer causes & control : CCC · 2013
    Article
15. Riluzole prodrugs for melanoma and ALS: design, synthesis, and in vitro metabolic profiling.Bioorganic & medicinal chemistry · 2012
    Article
16. Expression of glutamate receptor subunits in human cancers.Histochemistry and cell biology · 2009
    Article
17. Effects of the neonatal treatment with monosodium glutamate on myenteric neurons and the intestine wall in the ileum of rats.Journal of gastroenterology · 2006
    Article
18. Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development.Journal of molecular medicine (Berlin, Germany) · 2004
    Review

Corrections and comments

• Comment on
  Glutamate antagonists limit tumor growth.2001

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as